Background Pulmonary embolism is a potentially life‐threatening condition in which a clot
can travel from the deep veins, most commonly in the leg, up to the lungs. Previously, a …

Objective: The objective of this review is to examine the management strategies for
pulmonary embolism (PE) with an emphasis of the role of direct oral anticoagulants …

Pulmonary embolism (PE) is a relatively common cardiovascular emergency. PE and deep
vein thrombosis (DVT) are considered expressions of the same disease, termed as venous …

Background Deep vein thrombosis (DVT) is a condition in which a clot forms in the deep
veins, most commonly of the leg. It occurs in approximately 1 in 1,000 people. If left …

Direct oral anticoagulants are as effective as conventional anticoagulant treatment after
pulmonary embolism with a reduction in major bleeding when the single-drug approach was …

Background Deep vein thrombosis (DVT) is a condition in which a clot forms in the deep
veins, most commonly of the leg. It occurs in approximately one in 1000 people. If left …

Anticoagulation therapy is mandatory in patients with pulmonary embolism to prevent
significant morbidity and mortality. The mainstay of therapy has been vitamin‐K antagonist …

Limited information exists on the safety and efficacy of non-vitamin K oral anticoagulants
(NOACs) in patients with pulmonary embolism (PE). The aim of this study is to evaluate the …

Pulmonary embolism (PE), which can develop as a consequence of deep vein thrombosis
(DVT), is a serious and potentially fatal venous thromboembolic event. Patients with PE are …

Background Direct oral anticoagulants that target a single coagulation factor have been
developed as an alternative to standard therapies with heparin and/or vitamin K antagonists …